Literature DB >> 19496984

Successful cord blood transplantation using a reduced-intensity conditioning regimen for advanced childhood-onset cerebral adrenoleukodystrophy.

Tomonari Awaya1, Takeo Kato, Akira Niwa, Hidefumi Hiramatsu, Katsutsugu Umeda, Ken-Ichiro Watanabe, Minoru Shibata, Yasunari Yamanaka, Etsuko Maruya, Hiroh Saji, Tatsutoshi Nakahata, Souichi Adachi.   

Abstract

The CCALD, which is caused by a mutation of the ABCD1 gene that encodes a peroxisomal membrane protein, progresses to a stage where the patient is in a vegetative state and can cause death within 3-5 yr after the appearance of neurological symptoms. Although HSCT is the only means of preventing the progression of this disease, HSCT is currently recommended only for cases diagnosed in the early stages. Previous reports on HSCT in advanced CCALD have indicated that the complications of the HSCT procedure seem to outweigh its benefits with respect to survival and neurological outcome. In this case, we successfully treated advanced CCALD with CBT using a reduced-intensity conditioning regimen to reduce regimen-related toxicity and transplant-associated morbidity and mortality. Neither neurological deterioration nor deterioration of MRI abnormalities were observed during the clinical course. We report that CBT using the reduced-intensity conditioning regimen was well tolerated, stopped disease progression and contributed to a good neuropsychological outcome in this case of advanced CCALD.
© 2009 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19496984     DOI: 10.1111/j.1399-3046.2009.01188.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  6 in total

1.  Determination of intracellular fludarabine triphosphate in human peripheral blood mononuclear cells by LC-MS/MS.

Authors:  Liusheng Huang; Patricia Lizak; Francesca Aweeka; Janel Long-Boyle
Journal:  J Pharm Biomed Anal       Date:  2013-08-23       Impact factor: 3.935

Review 2.  Recent trends in mucopolysaccharidosis research.

Authors:  Hiroshi Kobayashi
Journal:  J Hum Genet       Date:  2018-11-19       Impact factor: 3.172

Review 3.  The Vegetative State and Stem Cells: Therapeutic Considerations.

Authors:  Alan S Hazell
Journal:  Front Neurol       Date:  2016-08-23       Impact factor: 4.003

4.  Allogeneic stem cell transplantation with reduced intensity conditioning for patients with adrenoleukodystrophy.

Authors:  Koji Kato; Ryo Maemura; Manabu Wakamatsu; Ayako Yamamori; Motoharu Hamada; Shinsuke Kataoka; Atsushi Narita; Shunsuke Miwata; Yuko Sekiya; Nozomu Kawashima; Kyogo Suzuki; Kotaro Narita; Sayoko Doisaki; Hideki Muramatsu; Hirotoshi Sakaguchi; Kimikazu Matsumoto; Yuka Koike; Osamu Onodera; Makiko Kaga; Nobuyuki Shimozawa; Nao Yoshida
Journal:  Mol Genet Metab Rep       Date:  2018-11-20

5.  Low donor chimerism may be sufficient to prevent demyelination in adrenoleukodystrophy.

Authors:  Takahiro Ikeda; Yuta Kawahara; Akihiko Miyauchi; Hitomi Niijima; Rieko Furukawa; Nobuyuki Shimozawa; Akira Morimoto; Hitoshi Osaka; Takanori Yamagata
Journal:  JIMD Rep       Date:  2021-11-17

6.  Brain-sparing cord blood transplantation for the borderline stage of adrenoleukodystrophy.

Authors:  Yutaro Yada; Michiko Torio; Yuhki Koga; Fumiya Yamashita; Takuya Ichimura; Katsuhide Eguchi; Masataka Ishimura; Yuichi Mushimoto; Akio Hiwatashi; Momoko Sasazuki; Ryutaro Kira; Yasunari Sakai; Shouichi Ohga
Journal:  Mol Genet Metab Rep       Date:  2021-06-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.